On October 14th, Maccura Biotechnology (300463.SZ) announced that the company recently received the "Medical Instruments Registration Certificate (In-Vitro Diagnostic Reagents)" issued by the Sichuan Provincial Pharmaceutical Supervision and Administration Bureau, with the product name being Gastric Function Quality Control Product.
The Gastric Function Quality Control Product is a new quality control product on the company's immune platform, mainly used for quality control of the company's PGI, PGII, and G-17 projects. The new product's registration certificate further enriches the company's product portfolio, helps enhance the company's overall market competitiveness, and will have a positive impact on market expansion and the company's future operation.
